Glucagon like Peptide 1 (GLP – 1) Agonists Market 2024: Trends and Growth, Segmentation and Key Companies

Glucagon like Peptide 1 (GLP - 1) Agonists

Glucagon like Peptide 1 (GLP – 1) Agonists Market” report provides strategic supports mentioned by the business specialists with market sources, amount of manufacturing cost structure, raw materials, forecasts, turnover, manufacturing outlays, latest market trends, labor cost, demands and much more. Glucagon like Peptide 1 (GLP – 1) Agonists market report covers a comprehensive market structure through the globe with an in-depth study of major dynamics (Drivers, Challenges, Opportunities).  

Request a sample copy of the report – https://www.absolutereports.com/enquiry/request-sample/13999732

Key Market Trends: – Constant Global Trend of High Diabetes Prevalence

The sales of GLP-1 are directly proportional to the global trend of high diabetes prevalence.
For instance, the percentages of type 2 diabetes in a few significant countries are as follows: China 22.8%, Oman 17.2%, 12.9%, and so on.
It is estimated, worldwide, that approximately USD 8.39 billion is spent on diabetes. The growth in the number of middle-class households, as well as increasing per capita income in these countries, are expected to result in better spending power in general, thereby helping to drive the market during the forecast period (2019-2024).
Along with this, a few critical factors, such as advanced healthcare infrastructure, technological advancement, and availability of skilled medical professionals, are likely to play paradigm shifting roles in the overall growth of this market.

North to Dominate the Market in Terms of Revenue

North accounts for 77% of the overall GLP-1 market and is expected to witness a growth rate of 6.53%, during the forecast period.
In the Middle East & Africa, the GLP-1 market is expected to see high growth during the forecast period, with a CAGR of 25.08%.
In Asia-Pacific, according to the International Diabetes Federation, Japan and Australia have the highest per capita expenditure, of upwards of USD 3,000. However, China and have the highest diabetes prevalence.

Market Overview:

  • The glucagon-like peptide-1 (GLP-1) agonists market is expected to see a considerable amount of growth during the forecast period. The increase is mainly attributed to the improved efficiency of GLP-1.
  • Increasing diabetes prevalence in established and emerging countries is expected to drive the market. The increase in the diabetic population over the years is due to the overall effect of individual-level factors, like the increasing median age of the population and health factors, including increasing rates of obesity and inactivity levels among people.
  • In addition, lowering birth rates, along with increasing life expectancy, in countries like Japan, Italy, , and which have a high percentage of the geriatric population, are expected to drive the growth of the market.Novo Nordisk Victoza held a 55% market share in the GLP-1 agonist market in 2017, but it is expected that Eli Lilly’s Trulicity will dominate the market during the forecast period.

    Key Manufacturers Like 

  • NovoNordisk
  • Sanofi
  • Eli Lilly
  • AstraZeneca.

    Scope of the Report:

  • The market is segmented by the drug (Exenatide, Liraglutide, Dulaglutide, Lixisenatide), by brand (Byetta, Bydureon, Victoza, Trulicity, Lyxumia) and by geography.

    Glucagon like Peptide 1 (GLP – 1) Agonists market report focuses on the latest trends in the global and regional spaces on all the significant components, including the capacity, cost, price, technology, supplies, production, profit, and competition. Moreover, the old data and present development of the Glucagon like Peptide 1 (GLP – 1) Agonists market have been given in the scope of the report. The latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Glucagon like Peptide 1 (GLP – 1) Agonists market have also been involved in the study.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    Inquire Or Share Your Questions If Any Before The Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/13999732

    Key Questions Answered in Market Report: –

    • What will the market growth rate, Overview and Analysis by Type of Glucagon like Peptide 1 (GLP – 1) Agonists market in 2023?
    • What are the key factors driving, Analysis by Applications and Countries Glucagon like Peptide 1 (GLP – 1) Agonists market?
    • What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Glucagon like Peptide 1 (GLP – 1) Agonists?
    • Who are Opportunities, Risk and Driving Force of Glucagon like Peptide 1 (GLP – 1) Agonists market? Knows Upstream Raw Materials Sourcing and Downstream Buyers
    • Who are the opportunities and threats faced by the vendors in Glucagon like Peptide 1 (GLP – 1) Agonists space? Business Overview by Type, Applications, Gross Margin and Market Share
    • What are the Glucagon like Peptide 1 (GLP – 1) Agonists market opportunities, market risk and market overview of the Market?

    Lastly, the Global Glucagon like Peptide 1 (GLP – 1) Agonists Market Research covers a complete market structure across the world with a comprehensive analysis of major key factors. This report provides planned orientations referred by the industry experts.

    Purchase This Report (Price 5000 USD for single user license) – https://www.absolutereports.com/purchase/13999732   

    Study objectives of Glucagon like Peptide 1 (GLP – 1) Agonists Market Report:

    • To provide a detailed analysis of the market structure along with the Glucagon like Peptide 1 (GLP – 1) Agonists market forecast of various segments and sub-segments of the Glucagon like Peptide 1 (GLP – 1) Agonists market
    • To provide insights into factors influencing and affecting market growth
    • To provide historical, current, and forecast revenue of market segments based on material, type, design, and end user
    • To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
    • To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
    • To provide economic factors, technology and Glucagon like Peptide 1 (GLP – 1) Agonists market trends that influence the global Glucagon like Peptide 1 (GLP – 1) Agonists market

    Detailed TOC of Glucagon like Peptide 1 (GLP – 1) Agonists Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Drug
    5.1.1 Exenatide
    5.1.1.1 Byetta (Value and Volume 2012-2024)
    5.1.1.2 Bydureon (Value and Volume 2012-2024)
    5.1.2 Liraglutide
    5.1.2.1 Victoza (Value and Volume 2012-2024)
    5.1.3 Lixisenatide
    5.1.3.1 Lyxumia (Value and Volume 2012-2024)
    5.1.4 Dulaglutide
    5.1.4.1 Trulicity (Value and Volume 2012-2024)
    5.2 Geography
    5.2.1 North
    5.2.1.1 US (Value and Volume 2012-2024)
    5.2.1.1.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.1.1.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.1.2 Canada (Value and Volume 2012-2024)
    5.2.1.2.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.1.2.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.1.3 Rest of North (Value and Volume 2012-2024)
    5.2.1.3.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.1.3.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.2 Europe
    5.2.2.1 (Value and Volume 2012-2024)
    5.2.2.1.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.2.1.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.2.2 Spain (Value and Volume 2012-2024)
    5.2.2.2.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.2.2.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.2.3 Italy (Value and Volume 2012-2024)
    5.2.2.3.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.2.3.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.2.4 (Value and Volume 2012-2024)
    5.2.2.4.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.2.4.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.2.5 UK (Value and Volume 2012-2024)
    5.2.2.5.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.2.5.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.2.6 Russia (Value and Volume 2012-2024)
    5.2.2.6.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.2.6.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.2.7 Rest of Europe (Value and Volume 2012-2024)
    5.2.2.7.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.2.7.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3 Asia-Pacific
    5.2.3.1 Japan (Value and Volume 2012-2024)
    5.2.3.1.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.1.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3.2 China (Value and Volume 2012-2024)
    5.2.3.2.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.2.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3.3 Australia (Value and Volume 2012-2024)
    5.2.3.3.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.3.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3.4 (Value and Volume 2012-2024)
    5.2.3.4.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.4.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3.5 South Korea (Value and Volume 2012-2024)
    5.2.3.5.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.5.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3.6 (Value and Volume 2012-2024)
    5.2.3.6.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.6.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3.7 Indonesia (Value and Volume 2012-2024)
    5.2.3.7.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.7.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3.8 Thailand (Value and Volume 2012-2024)
    5.2.3.8.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.8.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3.9 Philippines (Value and Volume 2012-2024)
    5.2.3.9.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.9.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.3.10 Rest of Asia-Pacific (Value and Volume 2012-2024)
    5.2.3.10.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.3.10.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.4 Latin
    5.2.4.1 Brazil (Value and Volume 2012-2024)
    5.2.4.1.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.4.1.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.4.2 Mexico (Value and Volume 2012-2024)
    5.2.4.2.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.4.2.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.4.3 Rest of Latin (Value and Volume 2012-2024)
    5.2.4.3.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.4.3.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.5 Middle East & Africa
    5.2.5.1 South Africa (Value and Volume 2012-2024)
    5.2.5.1.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.5.1.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.5.2 Saudi Arabia (Value and Volume 2012-2024)
    5.2.5.2.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.5.2.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.5.3 Oman (Value and Volume 2012-2024)
    5.2.5.3.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.5.3.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.5.4 Egypt (Value and Volume 2012-2024)
    5.2.5.4.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.5.4.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.5.5 Iran (Value and Volume 2012-2024)
    5.2.5.5.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.5.5.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)
    5.2.5.6 Rest of Middle East & Africa (Value and Volume 2012-2024)
    5.2.5.6.1 By Drug (Exenatide, Liraglutide, Lixisenatide, and Dulaglutide)
    5.2.5.6.2 By Company (Novo Nordisk, Sanofi, Eli Lilly, and AstraZeneca)

    6 MARKET INDICATORS
    6.1 Type-1 Diabetes Population (2012-2024)
    6.2 Type-2 Diabetes Population (2012-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 COMPANY PROFILES
    7.1.1 Novo Nordisk
    7.1.2 Sanofi
    7.1.3 Eli Lilly
    7.1.4 AstraZeneca
    7.2 MARKET SHARE ANALYSIS
    7.2.1 Novo Nordisk
    7.2.2 Sanofi
    7.2.3 Eli Lilly
    7.2.4 AstraZeneca

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

    Purchase This Report (Price 5000 USD for single user license) –https://www.absolutereports.com/purchase/13999732

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other report :
    Steam Meters Market 2021-2026| Market Size Estimation, Introduction and Market Overview, Market Scope and Growth

    Coextruded Cast Polypropylene (CPP) Films Market 2021| Analysis by Key Players, Industry Growth, Size, Share, Trends, Sales Forecast and Supply Demand to 2027

    Semi-precious Jewelry Market 2021-2027: Market Size, Industry Analysis, Market Trends, Growth, Opportunities, and Forecast

    Biostimulants Market 2021: Market Segmentation, Size, Share, Growth Analysis, Technology and Market Analysis Research Report to 2026

    New Energy Vehicle Motor Driver Market Research 2021-2027| Region Wise Analysis of Top Players in Market by its Types and Application

    Photovoltaics Market 2021 – 2026: Size, Top Companies, Trends, Mergers & Acquisitions and Expansion Plans and New Project Feasibility Analysis

    AlN Ceramic Substrates Market 2021: Industry Updates Future Growth, Prominent Players, Business Prospects, Forthcoming Developments and Future Investments by Forecast to 2027

    Depression Drugs Market Analysis, Market Size, Growth, Competitive Insight and Key Drivers, Research Report 2021-2027

    Chemical Concentration Monitors Market 2021: Market Growth, Size, Opportunities, Leading Company Analysis, Share, Trends, Regional Overview, and Key Country Forecast to 2027

    Retort Pouch Market 2021: Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities & Future Potential 2027

    Electric AC Motors Market 2021: Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities & Future Potential 2027

    Heart Pump Market 2021: Overview, Trends, Drivers, Challenges, Restraints, Key Players Analysis, Growth Opportunities and Forecast 2026

    Bird Flu Treatment Market Overview, Type, Manufacturing Base and Competitors, Sales, Revenue, Growth Rate and Forecast (2021-2027)

    AC Signal Relays Market Analysis by Size, Share, Key Drivers, Growth Opportunities and Trends 2021 – 2027

    Vial Adaptors for Reconstitution Drug Market 2021: Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities & Future Potential 2027

    Heat-Resistant Fabric Market 2021: Market Segmentation, Size, Share, Growth Analysis, Technology and Market Analysis Research Report to 2026

    Sack Trucks Market 2021: Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities & Future Potential 2027

    Badminton Market 2021 Growth by Manufacturers, Regions, Type and Application, Production, Revenue, Price and Gross Margin Analysis to 2026

    Fire Sprinklers System Market 2021: Subdivision, Forthcoming Developments, Growth Challenges, Opportunities, Top Key Players and Forecast 2027

    Semiconductor Silicon Wafer Market 2021: Top Leading Countries, Consumption, Drivers, Companies, Trends, Forces Analysis, Revenue, Challenges and Global Forecast 2027

    Capsulated Cork Stoppers Market 2021: Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities & Future Potential 2027

    Guest Messaging Software Market 2021 – 2026: Size, Top Companies, Trends, Mergers & Acquisitions and Expansion Plans and New Project Feasibility Analysis

    Drinking Straws Market Size 2021: Industry Share, Leading Players, Emerging Demand, CAGR, Market Development Constraints and Drivers

    Overvoltage Spark Gaps Market Outlook 2021-2027: Top Companies, Trends and Future Prospects Details for Business Development

    Protein Crystallization & Crystallography Market Size and Share 2021| Market Overview, Covering COVID-19 Impact Analysis and Forecast to 2027

    Sedan Glass Encapsulation Market 2020-2024: Size, Share, Emerging Trends, Demand, Revenue and Forecasts Research

    Orthopedic Shoes Market 2021 Market Size, Share, Trends Analysis and Growth Forecast to 2027

    Guitar Capos Market 2021: Trending Technologies, Worldwide Market Growth, Segmentation, Size, Developments in Manufacturing Skill and Regional Growth Overview

    Spinal Operating Tables Market 2021 analysis with Key Players, Applications, Trends and Forecasts by 2027

    Sucker Rod Market 2021: Industry Updates Future Growth, Prominent Players, Business Prospects, Forthcoming Developments and Future Investments by Forecast to 2027

    Global Reheat Steam Turbines Market by Segmentation, company Sales and Revenue, Production Capacity Forecasted by Region 2021 – 2027

    Carbon Fiber Heating Wires Market 2021: Detailed Qualitative Analysis, Factors Details for Business Development, Top Companies, Trends and Forecast 2027

    Anti-counterfeit Pharmaceuticals and Cosmetics Packaging Market 2021: Market Definition, Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2030

    Adhesive Films Market Research Report Overview by Industry Dynamics, Regional Analysis and Forecast 2021 to 2026

    Digital Scales Market Breakdown with Impact of COVID 19, Growth by Top Company, Region, Application, Driver, Trends and Forecasts by 2027

    Optical Chemical Sensors Market – Global Industry Analysis, Growth, Size, Share, Trends and Estimate by 2021 – 2027

    Electric & Hybrid Electric Buses Global Market to 2026 – Segmentation by Product Type, Application, Increasing Trends and Growth

    Mechanical Brake Market 2021 Sales Overview, Market Size, Growth Opportunities and Restraint to 2027

    WLAN Front-end Modules Market 2021: Key Players Analysis, Development Status, Emerging Technologies, Sales Revenue, Opportunity Assessment and Industry Expansion Strategies 2027

    Zwitterionic Surfactants Market 2021: Market Share, Global Trend, Industry Demand, Business Growth, Top Key Players, Business Statistics and Research Methodology by Forecast to 2027

    Atipamezole Market – Global Industry Analysis, Growth, Size, Share, Trends and Estimate by 2021 – 2027

    Rotary Mower Market 2020-2024: Size, Share, Emerging Trends, Demand, Revenue and Forecasts Research

    Battery Material Market Outlook to 2026: Emerging Trends, Market Size, Share, Growth and Opportunities Status

    Laboratory Refrigerator Market 2021: Analysis by Product Type, Applications, Regional Outlook, Technology, Opportunity and Forecast 2027

    Endpoint Detection And Response (EDR) Solutions Market 2021 – 2026: Size, Top Companies, Trends, Mergers & Acquisitions and Expansion Plans and New Project Feasibility Analysis

    Binders For Lithium Ion Batteries Market Research Report Overview by Industry Dynamics, Regional Analysis and Forecast 2021 to 2026

    Uniforms and Workwear Market 2021 – 2027: Market Share Analysis by Manufacturers, Regions, Type and Application

  • Leave a Reply

    Your email address will not be published. Required fields are marked *